A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata.

Kristof Chwalisz,Lois Larsen,Cynthia Mattia-Goldberg,Anthony Edmonds,Walter Elger,Craig A Winkel

Fertility and Sterility（2007）

引用 139|浏览17

暂无评分

摘要

After 12-week treatment, asoprisnil controlled uterine bleeding while reducing leiomyoma volume and the associated pressure symptoms. Asoprisnil was well tolerated.

查看译文

关键词

amenorrhea,asoprisnil (J867),leiomyoma,pelvic pressure,selective progesterone receptor modulators (SPRMs),menorrhagia,progesterone receptor,endometrium

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要